Clinicopathologic features of early vs late recurrence of HR+,HER2- EBC
Dr. O’Shaughnessy elaborates on the spectrum of high-risk HER+,HER2- early breast cancer and discusses the clinicopathologic features associated with early and late recurrence.
Date of Last Review: February 14, 2023
Document Number: VV-MED-135247
Clinicopathologic features of early vs late recurrence of HR+,HER2- EBC
is now playing
1:28
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice